Deutsch English Français

Contact

EP1859797

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1859797

EP1859797 - CONCOMITANT USE OF SULFONAMIDE COMPOUND WITH ANTI-CANCER AGENT [Right-click to bookmark this link]
Former [2007/48]	NOVEL CONCOMITANT USE OF SULFONAMIDE COMPOUND WITH ANTI-CANCER AGENT
	[2014/21]
Status	The application is deemed to be withdrawn Status updated on 13.02.2015 Database last updated on 31.08.2024
Most recent event Tooltip	13.02.2015	Application deemed to be withdrawn	published on 18.03.2015 [2015/12]
Applicant(s)	For all designated states Eisai R&D Management Co., Ltd. 6-10, Koishikawa 4-chome, Bunkyo-ku Tokyo 112-8088 / JP
	[2007/48]
Inventor(s)	01 / OWA, Takashi c/o Tsukuba Res. Labs, Eisai Co., Ltd. 1-3, Tokodai 5-chome Tsukuba-shi Ibaraki 3002635 / JP
	02 / OZAWA, Yoichi Tsukuba Res. Labs, Eisai Co., Ltd. 1-3, Tokodai 5-chome Tsukuba-shi Ibaraki 3002635 / JP
	03 / SEMBA, Taro Tsukuba Res. Labs, Eisai Co., Ltd 1-3, Tokodai 5-chome Tsukuba-shi, Ibaraki 3002635 / JP
	04 / HATA, Naoko Tsukuba Res. Labs, Eisa Co., Ltd 1-3, Tokodai 5-chome Tsukuba-shi, Ibaraki 3002635 / JP
	[2007/48]
Representative(s)	Woods, Geoffrey Corlett, et al J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB
	[N/P]
Former [2007/48]	Woods, Geoffrey Corlett, et al J.A. KEMP & CO. Gray's Inn 14 South Square London WC1R 5JJ / GB
Application number, filing date	06715262.9	28.02.2006
	[2007/48]
	WO2006JP304219
Priority number, date	JP20050055132	28.02.2005 Original published format: JP 2005055132
	[2007/48]
Filing language	JA
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2006090931
	Date:	31.08.2006
	Language:	JA
	[2006/35]
	Type:	A1 Application with search report
	No.:	EP1859797
	Date:	28.11.2007
	Language:	EN
	[2007/48]
Search report(s)	International search report - published on:	JP	31.08.2006
	(Supplementary) European search report - dispatched on:	EP	15.03.2011
Classification	IPC:	A61K31/18, A61K31/343, A61K31/381, A61K31/404, A61K31/4741, A61K31/498, A61K31/7068, A61K33/24, A61K45/06, A61P9/00, A61P35/00	[2011/15]
	CPC:	A61K31/498 (EP,US); A61K31/18 (EP,US); A61K31/343 (EP,US); A61K31/381 (EP,US); A61K31/404 (EP,US); A61K31/4741 (EP,US); (+) A61K31/7068 (EP,US); A61K33/243 (EP,US); A61K45/06 (EP,US); A61P35/00 (EP); A61P43/00 (EP); A61P9/00 (EP) (-)
	C-Set:	A61K31/18, A61K2300/00 (US,EP); A61K31/343, A61K2300/00 (US,EP); A61K31/381, A61K2300/00 (US,EP); A61K31/404, A61K2300/00 (US,EP); (+) A61K31/4741, A61K2300/00 (EP,US); A61K31/498, A61K2300/00 (EP,US); A61K31/7068, A61K2300/00 (EP,US); A61K33/24, A61K2300/00 (EP,US) (-)
	Former IPC [2007/48]	A61K31/404, A61K31/18, A61K31/343, A61K31/381, A61K31/4741, A61K31/498, A61K31/7068, A61K33/24, A61K45/00, A61P9/00, A61P35/00
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/48]
Extension states	AL	25.09.2007
	BA	25.09.2007
	HR	25.09.2007
	MK	25.09.2007
	YU	25.09.2007
Title	German:	GLEICHZEITIGE VERWENDUNG EINER SULFONAMID-VERBINDUNG UND EINES MITTELS GEGEN KREBS	[2014/21]
	English:	CONCOMITANT USE OF SULFONAMIDE COMPOUND WITH ANTI-CANCER AGENT	[2014/21]
	French:	UTILISATION CONCOMITANTE D'UN COMPOSE DE SULFONAMIDE AVEC UN AGENT ANTI-CANCER	[2014/21]
	Former [2007/48]	NEUE GLEICHZEITIGE VERWENDUNG EINER SULFONAMID-VERBINDUNG UND EINES MITTELS GEGEN KREBS
	Former [2007/48]	NOVEL CONCOMITANT USE OF SULFONAMIDE COMPOUND WITH ANTI-CANCER AGENT
	Former [2007/48]	NOUVELLE UTILISATION CONCOMITANTE D'UN COMPOSE DE SULFONAMIDE AVEC UN AGENT ANTI-CANCER
Entry into regional phase	25.09.2007	Translation filed
	25.09.2007	National basic fee paid
	25.09.2007	Search fee paid
	25.09.2007	Designation fee(s) paid
	25.09.2007	Examination fee paid
Examination procedure	25.09.2007	Examination requested [2007/48]
	04.10.2011	Amendment by applicant (claims and/or description)
	10.05.2012	Despatch of a communication from the examining division (Time limit: M04)
	03.09.2012	Reply to a communication from the examining division
	28.04.2014	Communication of intention to grant the patent
	09.09.2014	Application deemed to be withdrawn, date of legal effect [2015/12]
	15.10.2014	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2015/12]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 10.05.2012
Fees paid	Renewal fee
	13.02.2008	Renewal fee patent year 03
	13.02.2009	Renewal fee patent year 04
	16.02.2010	Renewal fee patent year 05
	15.02.2011	Renewal fee patent year 06
	22.02.2012	Renewal fee patent year 07
	21.02.2013	Renewal fee patent year 08
	20.02.2014	Renewal fee patent year 09
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[YA]EP1331005 (EISAI CO LTD [JP]) [Y] 1,8,9,11,14-16,20,21,25,27,28 * paragraphs [0001] - [0002] - [0 37] * * claims 1, 3, 5-19 * [A] 2,13,19,24;
		[YA]WO2004026872 (SCHERING CORP [US]) [Y] 1,8,9,11,14-16,20,21,25,27,28 * page 24, line 29 - page 26, line 7 * [A] 2,13,19,24;
		[XAY]EP1481678 (EISAI CO LTD [JP]) [X] 9,14,25,27,28 * paragraphs [0002] - [0003] * * paragraphs [0033] - [0035]; examples 1-4; tables 1-4 * [A] 2,13,19,24 [Y] 1,8,9,11,14-16,20,21,25,27,28;
		[A] - SHIMIZU K ET AL, "Cancer anti-angiogenic therapy", BIOLOGICAL & PHARMACEUTICAL BULLETIN (OF JAPAN), PHARMACEUTICAL SOCIETY OF JAPAN, TOKYO, JP LNKD- DOI:10.1248/BPB.27.599, (20040501), vol. 27, no. 5, ISSN 0918-6158, pages 599 - 605, XP002483110 [A] 1,2,8,9,11,13-16,19-21,24,25,27,28 * abstract * * table 1 * DOI: http://dx.doi.org/10.1248/bpb.27.599
		[A] - FUKUOKA K ET AL, "Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells", INVESTIGATIONAL NEW DRUGS, MARTINUS NIJHOFF PUBLISHERS, BOSTON, US LNKD- DOI:10.1023/A:1010608317361, (20010101), vol. 19, no. 3, ISSN 0167-6997, pages 219 - 227, XP002483112 [A] 1,2,8,9,11,13-16,19-21,24,25,27,28 * abstract * * figure 1 * DOI: http://dx.doi.org/10.1023/A:1010608317361

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p